DE602006021777D1 - Diagnoseverfahren für präeklampsie - Google Patents

Diagnoseverfahren für präeklampsie

Info

Publication number
DE602006021777D1
DE602006021777D1 DE602006021777T DE602006021777T DE602006021777D1 DE 602006021777 D1 DE602006021777 D1 DE 602006021777D1 DE 602006021777 T DE602006021777 T DE 602006021777T DE 602006021777 T DE602006021777 T DE 602006021777T DE 602006021777 D1 DE602006021777 D1 DE 602006021777D1
Authority
DE
Germany
Prior art keywords
sbp
proteinaceous
sflt
plgf
clamping
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602006021777T
Other languages
English (en)
Inventor
David C Sogin
Donald M Laird
Zhiguang Yu
Robert C Doss
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37820640&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE602006021777(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Publication of DE602006021777D1 publication Critical patent/DE602006021777D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/36—Gynecology or obstetrics
    • G01N2800/368—Pregnancy complicated by disease or abnormalities of pregnancy, e.g. preeclampsia, preterm labour

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Reproductive Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Vehicle Body Suspensions (AREA)
  • Pressure Welding/Diffusion-Bonding (AREA)
DE602006021777T 2005-11-14 2006-11-14 Diagnoseverfahren für präeklampsie Active DE602006021777D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US73665905P 2005-11-14 2005-11-14
US11/367,126 US20070111326A1 (en) 2005-11-14 2006-03-03 Diagnostic method for proteinaceous binding pairs, cardiovascular conditions and preeclampsia
PCT/US2006/044059 WO2007059065A2 (en) 2005-11-14 2006-11-14 Diagnostic method for proteinaceous binding pairs, cardiovascular conditions and preeclampsia

Publications (1)

Publication Number Publication Date
DE602006021777D1 true DE602006021777D1 (de) 2011-06-16

Family

ID=37820640

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602006021777T Active DE602006021777D1 (de) 2005-11-14 2006-11-14 Diagnoseverfahren für präeklampsie

Country Status (8)

Country Link
US (1) US20070111326A1 (de)
EP (1) EP1952156B1 (de)
JP (1) JP5225097B2 (de)
AT (1) ATE508364T1 (de)
CA (1) CA2629451A1 (de)
DE (1) DE602006021777D1 (de)
ES (1) ES2363609T3 (de)
WO (1) WO2007059065A2 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102005022047A1 (de) 2005-05-09 2006-11-30 Dade Behring Marburg Gmbh Bindungspartner des Plazentalen Wachstumsfaktors insbesondere gegen den Plazentalen Wachstumsfaktor gerichtete Antikörper, ihre Herstellung und Verwendung
US20080071151A1 (en) * 2006-06-30 2008-03-20 Sogin David C Method and Apparatus for Diagnosing Pre-eclampsia
EP1903339B1 (de) * 2006-09-20 2010-08-04 Roche Diagnostics GmbH Natriurethische Peptide und Plazenta-Wachstumfaktor/löslicher VEGF-Rezeptor unterscheiden zwischen mit der Plazenta verbundener Herzdysfunktion und mit Herzerkrankung verbundener Herzdysfunktion
DE102007038730A1 (de) * 2007-08-16 2009-02-19 Carl Zeiss Meditec Ag Nachweis des menschlichen Vascular Endothelial Growth Factor
RU2523887C2 (ru) 2008-01-07 2014-07-27 Орто-Клиникал Дайэгностикс, Инк. Калибратор/регулятор для синхронного анализа белков, способных к комплексообразованию друг с другом
EP2235529B1 (de) * 2008-01-07 2016-12-14 Ortho-Clinical Diagnostics, Inc. Bestimmung des sflt-1:angiogenesefaktorkomplexes
US20100004306A1 (en) * 2008-06-18 2010-01-07 Abbott Laboratories PIGF-1 Assay and kits and components thereof
US8741287B2 (en) 2008-06-18 2014-06-03 Abbott Laboratories PlGF-1 assay and kits and components thereof
CA2743570A1 (en) * 2008-11-20 2010-05-27 Perkinelmer Health Sciences, Inc. Method for determining the risk of pre-eclampsia using pigf-2 and pigf-3 markers
WO2010151329A1 (en) * 2009-06-24 2010-12-29 Seventh Sense Biosystems, Inc. Assays involving colorimetric signaling
EP2776839B1 (de) * 2011-11-09 2017-08-30 Roche Diagnostics GmbH Dynamik des sflt-1 oder endoglin/plgf-verthältnisses als indikator für drohende präeklampsie und/oder drohendes hellp-syndrom
CA2871878C (en) 2012-06-27 2021-08-10 F. Hoffmann-La Roche Ag Means and methods applying sflt-1/pigf or endoglin/pigf ratio to rule-out onset of preeclampsia within a certain time period
US10392665B2 (en) 2015-06-19 2019-08-27 Sera Prognostics, Inc. Biomarker pairs for predicting preterm birth
JP7080176B2 (ja) * 2016-02-29 2022-06-03 エフ．ホフマン－ラ ロシュ アーゲー 子癇前症におけるマーカーとしてのｉｇｆｂｐ－７
AU2018317902A1 (en) 2017-08-18 2020-03-05 Sera Prognostics, Inc. Pregnancy clock proteins for predicting due date and time to birth
MX2020002788A (es) 2017-09-13 2020-09-14 Progenity Inc Biomarcadores de preeclampsia y sistemas y metodos relacionados.
EP4070113A4 (de) 2019-12-04 2023-12-20 Biora Therapeutics, Inc. Beurteilung von präeklampsie unter verwendung von tests für freien und dissoziierten plazentalen wachstumsfaktor

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0114528A3 (de) * 1982-12-27 1986-05-14 Trustees Of Boston University Abscheidung von Zellen auf Platten unter Verwendung von Nicht-Antikörperliganden
AU614935B2 (en) * 1986-08-06 1991-09-19 Multilyte Limited Determination of analyte concentration using two labelling markers
CA2274675A1 (en) * 1996-12-20 1998-07-02 Ludwig Institute For Cancer Research Vegf-b/receptor complex and uses thereof
CA2348753A1 (en) * 1998-10-30 2000-05-11 Merska B.V. Screening for analytes using labeled receptors
NZ520171A (en) * 1999-12-20 2005-07-29 Immunex Corp Tweak receptor
WO2002099421A2 (en) * 2001-05-18 2002-12-12 Thomas Jefferson University Specific microarrays for breast cancer screening
WO2003022874A1 (en) * 2001-09-12 2003-03-20 Beijing Institute For Cancer Research Antagonist peptides to vegr receptor flt-1
EP1451579A4 (de) * 2001-11-19 2005-12-28 Protometrix Inc Verfahren zur verwendung eines nicht-antikörper-proteins zum nachweis und zur messung eines analyten
PT2308507E (pt) * 2002-07-19 2015-05-11 Beth Israel Hospital Métodos de tratamento de pré-eclâmpsia
US7435419B2 (en) * 2002-07-19 2008-10-14 Beth Israel Deaconess Medical Center Methods of diagnosing and treating pre-eclampsia or eclampsia
US7323346B2 (en) * 2003-08-14 2008-01-29 The General Hospital Corporation Screening for gestational disorders
JP4568282B2 (ja) * 2003-09-23 2010-10-27 ザ ジェネラル ホスピタル コーポレイション 妊娠性疾患のスクリーニング
EP1530047A1 (de) * 2003-11-07 2005-05-11 Roche Diagnostics GmbH Proximale Markermoleküle der Arterienthrombose und der Entzündung zur Risikostratifizierung einer koronaren Herzkrankheit
EP1615035B1 (de) * 2004-07-07 2007-06-06 F.Hoffmann-La Roche Ag Kombinationen von Markern zum Nachweis von typ 1 und 2 Diabetes
JP5009811B2 (ja) * 2004-12-21 2012-08-22 イェール ユニバーシティ 子癇前症の検出

Also Published As

Publication number Publication date
WO2007059065A3 (en) 2007-07-26
JP5225097B2 (ja) 2013-07-03
ATE508364T1 (de) 2011-05-15
ES2363609T3 (es) 2011-08-10
US20070111326A1 (en) 2007-05-17
EP1952156A2 (de) 2008-08-06
EP1952156B1 (de) 2011-05-04
CA2629451A1 (en) 2007-05-24
WO2007059065A2 (en) 2007-05-24
WO2007059065B1 (en) 2007-09-13
JP2009516170A (ja) 2009-04-16

Similar Documents

Publication Publication Date Title
DE602006021777D1 (de) Diagnoseverfahren für präeklampsie
MX2007014815A (es) Metodos de inmunoanalisis mejorados.
BRPI0707645B8 (pt) métodos in vitro para detecção de câncer em um indivíduo e para avaliação de prognóstico de um indivíduo tendo, ou suspeito de ter, câncer ovariano
NZ600828A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
TW200613729A (en) Diagnostic test strip for collecting and detecting an analyte in a fluid sample and method for using same
IL157380A0 (en) Mediator stabilized reagent compositions and methods for their use in electrochemical analyte detection assays
MX2009006205A (es) Inmunoensayo de multiples analitos.
TW200617380A (en) Concentration determination in a diffusion barrier layer
NZ599105A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
BRPI0812875A2 (pt) " método pra identificar se ou não um indivíduo está sob risco de desenvolvimento de sépsis severa, anticorpo específico para proteína ligante de heparina, método pra reduzir o risco de um indivíduo desenvolver sépsis severa, e, kit de teste ".
CA2701341A1 (en) Method of assessing colorectal cancer from a stool sample by use of the marker combination calprotectin and hemoglobin/haptoglobin complex
WO2009039170A3 (en) Integrated protein chip assay
WO2006092729A3 (en) Novel biomarkers for diagnosis and/or prognosis or prognosis of neoplasias in animals
ATE395812T1 (de) Methoden zur vorhersage eines schwangerschaftsergebnisses bei einer testperson mit hilfe eines hcg-tests
ATE474228T1 (de) Reagenz für hämoglobinabbau
Hindenberg et al. Evaluation of a species-specific C-reactive protein assay for the dog on the ABX Pentra 400 clinical chemistry analyzer
BRPI0618435A2 (pt) composição reagente de sensor teste tendo polìmeros de celulose adaptada para auxiliar na determinação de uma concentração de analito de uma amostra fluida, bem como processo de determinação de uma concentração de analito de uma amostra fluida
SI1977244T1 (sl) Razlikovanje med bakterijskim meningitisom in virusnim meningitisom
CY1109461T1 (el) Βελτιωμενες μεθοδοι ανοσολογικου προσδιορισμου
DE602005010548D1 (de) Verbessertes verfahren zur diagnose des akuten koronarsyndroms
Slocombe et al. A method for determining the concentration of haptoglobin in cattle blood following haemolysis caused at collection
DK1687636T3 (da) Hurtig bestemmelse af forskellige former for hepatocytvækstfaktor (HGF) i legemsvæsker
DE602004026869D1 (de) Diagnose von leberzirrhose mittels eines für menschliches protoonkogenes protein spezifischen antikörpers
ATE305980T1 (de) Verwendung von abfangsonden beim nachweis von nukleinsäuren